The Series A financing  announced Monday was coled by venture capital firm Forbion and European investor EQT Life Sciences alongside new backers that included Merck  Cos venture arm and the ALS Investment Fund. According to Forbion VectorYs financing is one of the largest funding rounds for a private biotech in Europe this year